Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4033193013 | Rimegepant only product in oromucosal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4033194019 | Product containing only rimegepant in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rimegepant only product in oromucosal dose form | Is a | Product containing rimegepant in oromucosal dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Rimegepant only product in oromucosal dose form | Is a | Rimegepant only product | true | Inferred relationship | Some | ||
| Rimegepant only product in oromucosal dose form | Has manufactured dose form | Oromucosal dose form (dose form) | true | Inferred relationship | Some | ||
| Rimegepant only product in oromucosal dose form | Plays role | Antimigraine therapeutic role (role) | true | Inferred relationship | Some | ||
| Rimegepant only product in oromucosal dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Rimegepant only product in oromucosal dose form | Has active ingredient | Rimegepant | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rimegepant (as rimegepant sulfate) 75 mg orodispersible tablet | Is a | False | Rimegepant only product in oromucosal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR